Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action

Diabetes

Volumn 46, Issue 11, 1997, Pages 1691-1700

  Kapur, Sonia ^a   Bédard, Sylvain ^a   Marcotte, Bruno ^a   Côté, Claude H ^a   Marette, André ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

EID: 0030714681     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1691     Document Type: Article

References (59)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991
2. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770, 1990
3. Schulz R, Triggle CR: Role of NO in vascular smooth muscle and cardiac muscle function. TIPS 15:255-259, 1994
4. Moncada S, Radomski MW, Palmer RMJ: Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495-2501, 1988
5. Nathan C, Hibbs JB: Role of nitric oxide synthesis in macrophage anti-microbial activity. Curr Opin Immunol 3:65-70, 1991
6. Schmidt HHHW, Walter U: NO at work. Cell 78:919-925, 1994
7. Hirai T, Visneski MD, Kearns KJ, Zelis R, Musch TI: Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. J Appl Physiol 77:1288-1293, 1994
8. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA: Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 90:2853-2858, 1994
9. G-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I. J Clin Invest 97:1319-1328, 1996
10. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187-E202, 1994
11. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
12. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
13. Baron AD: The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide. Diabetes 45 (Suppl. 1):S105-S109, 1996
14. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786-792, 1995
15. Kohlman O Jr., Neves FDA, Ginoza M, Tavares A, Cezaretti ML, Zanella MT, Ribeiro AB, Gavras I, Gavras H: Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. Hypertension 25:1003-1007, 1995
16. Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316:175-180, 1993
17. Kobzik L, Reid MB, Bredt DS, Stamler JS: Nitric oxide in skeletal muscle. Nature 372:546-548, 1994
18. Balon TW, Nadler JL: Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77:2519-2521, 1994
19. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752, 1995
20. Okuda S, Kanda F, Kawahara Y, Chihara K: Regulation of inducible nitric oxide synthase expression in L6 rat skeletal muscle cells. Am J Physiol 272:C35-C40, 1997
21. Gath I, Closs EI, Godtel-Armbrust U, Schmitt S, Nakane M, Wessler I, Forstermann U: Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J 10:1614-1620, 1996
22. Williams G, Brown T, Becker L, Prager M, Giroir BP: Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol 36:R1020-R1025, 1994
23. Shen W, Hintze TH, Wolin MS: Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92:3505-3512, 1995
24. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W, Hintze TH: Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc 27:1125-1134, 1995
25. Kobzik L, Stringer B, Balligand JL, Reid MB, Stamler JS: Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 211:375-381, 1995
26. Brown GC: Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369:136-139, 1995
27. Segal SS: Nitric oxide release is present from incubated skeletal muscle preparations (Editorial). J Appl Physiol 77:2517-2518, 1994
28. Balon TW, Nadler JL: Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82:359-363, 1997
29. Young ME, Radda GK, Leighton B: Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 322:223-228, 1997
30. Hansen PA, Gulve EA, Holloszy JO: Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:979-985, 1994
31. Klip A, Li G, Logan WJ: Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts. Am J Physiol 247 (Endocrinol Metab 10):E291-E296, 1984
32. Mitsumoto Y, Klip A: Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 267:4957-4962, 1992
33. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M, Klip A: Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose-transport, amino-acid-transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136:4315-4322, 1995
34. Gammeltoft S: Binding properties of insulin receptors in different tissues. In Insulin Receptors, Part A: Methods for the Study of Structure and Function. Harrison JCVLC, Ed., London, Alan R. Liss, 1988, p. 15-27
35. Verdon CP, Burton BA, Prior RL: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 224:502-508, 1995
36. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
37. Dombrowski L, Roy D, Marcotte B, Marette A: A new method for the isolation of plasma membranes, transverse tubules, and internal membranes from rat skeletal muscle. Am J Physiol 270 (Endo Metab 33):E667-E676, 1996
38. Hope BT, Michael GJ, Knigge KM, Vincent SR: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88:2811-2814, 1991
39. Brooke MH, Kaiser KK: Three "myosin ATPase" systems: nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem 18:670-677, 1970
40. Grozdanovic Z, Nakos G, Dahrmann G, Mayer B, Gossrau R: Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic striated muscle fibers. Cell Tissue Res 281:493-499, 1995
41. Silvagno F, Xia H, Bredt DS: Neuronal nitric-oxide synthase-μ, an alternative spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 271:11204-11208, 1996
42. Lee KH, Baek MY, Moon KY, Song WK, Chung CH, Ha DB, Rang M-S: Nitric oxide as a messenger molecule for myoblast fusion. J Biol Chem 269:14371-14374, 1994
43. Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R, Marcinkiewicz E, Korbut R, Gryglewski RJ: Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharmacol 46:553-566, 1994
44. Moilanen E, Vuorinen H, Kankaanranta T, Metsä-Ketelä T, Vapaatalo H: Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 109:852-858, 1993
45. Beckman JS, Koppenol WH: Nitric oxide, Superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996
46. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-SV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitro-compounds. Nature 364:626-632, 1993
47. Baron AD, Zhu JS, Marshall S, Irsula O, Brechtel G, Keech C: Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol 269:E709-E715, 1995
48. 2 uptake after inhibition of EDRF/NO synthesis. J Appl Physiol 76:1166-1171, 1994
49. Westfall MV, Sayeed MM: Basal- and insulin-stimulated muscle glucose transport in endotoxin and bacteremia rats. Am J Physiol 254:R673-R679, 1988
50. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52, 1992
51. Ling PR, Bistrian BR, Mendez B, Istfan NW: Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat-relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism 43:279-284, 1994
52. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
53. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
54. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
55. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF-α by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
56. Brune B, Lapetina EG: Activation of a cytosolic ADP-ribosyltransferase by nitric oxide generating agents. J Biol Chem 264:8455-8458, 1989
57. Antoine MH, Hermann M, Herchulez A, Lebrun P: Sodium nitroprusside inhibits glucose-induced insulin release by activating ATP-sensitive K+ channels. Biochem Biophys Acta 1175:293-301, 1993
58. Gupta S, McArthur C, Grady C, Ruderman NB: Stimulation of vascular Na+-K+-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol 266:H2146-H2151, 1994
59. Reid M: Reactive oxygen and nitric oxide in skeletal muscle. News Physiol Sci 11:114-119, 1996